Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement…
Physician-led company to use its AI-driven solution to bring speed, transparency and clinical expertise to reduce unnecessary care and increase…
A multi-stakeholder project to deliver an evidence-based, interoperable plan for safe, affordable aging at home aligned with federal technology priorities…
As the only health-tech app designed specifically for GLP-1 users who dine out — and for restaurants eager to welcome…
MURFREESBORO, TN / ACCESS Newswire / November 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will…
Company reaffirms its commitment to patient access, clinical excellence, and responsible reimbursement reform under the new CMS framework. MISSOULA, MT…
The milestone underscores Arkstone's leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding…
Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansionHORSHAM, Pa.,…
Winter Park, Florida--(Newsfile Corp. - November 5, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and…
SAN FRANCISCO, Nov. 4, 2025 /PRNewswire/ -- Today, Foodsmart, the leading evidenced based nutrition counseling and foodcare platform serving millions…